Nature Communications
An open access, multidisciplinary journal dedicated to publishing high-quality research in all areas of the biological, health, physical, chemical and Earth sciences.
Deuteration-enhanced neutron contrasts to probe amorphous domain sizes in organic photovoltaic bulk heterojunction films
This study unveils the amorphous nanomorphology of organic photovoltaics, employing neutron scattering and deuteration to enhance organic donor and acceptor contrast. It uncovers Y6's short-range aggregation within amorphous intermixed regions, pivotal for charge extraction and recombination.
An electroabsorption perspective on charge-transfer excitations in non-fullerene acceptors
Using electroabsorption spectroscopy to investigate intra- and intermolecular charge transfer excitations in Y6 and ITIC non-fullerene acceptors.
Solar-driven sugar production directly from CO2
We designed a hybrid electrocatalytic-biocatalytic flow system for achieving artificial synthesis of sugar directly from CO2.
Embracing Transboundary Interactions for Global SDGs Under the Metacoupling Framework
Countries should adopt a metacoupling-based governance approach that considers human-nature interactions within a country as well as across neighboring and non-neighboring countries.
Behind FISHnCHIPs
FISHnCHIPs simultaneously targets co-expressed gene groups, boosting signals 2-20 fold over single-gene methods. This enhanced sensitivity allows rapid, sensitive, and robust whole-tissue profiling under low magnification, and applicable for analyses of clinical tissue samples with low RNA quality.
Quantifying how Single Dose Ad26.COV2.S Vaccine Efficacy Depends on Spike Sequence Features
The phase 3 ENSEMBLE trial of a single dose of Janssen’s Ad26.COV2.S vaccine showed an overall vaccine efficacy of 56% against symptomatic COVID-19. Looking at the Spike sequences of infecting viruses reveals a more complex picture.